| Michael E Brun, MD | |
|
9100 W 74th St, Shawnee Mission, KS 66204-4004 | |
| (913) 676-2310 | |
| Not Available |
| Full Name | Michael E Brun |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 9100 W 74th St, Shawnee Mission, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568482669 | NPI | - | NPPES |
| 100123040B | Medicaid | KS | |
| 12497094 | Other | BCBS | |
| 203937917 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 04-21276 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael E Brun, MD 8000 W 110th St, Ste 150, Overland Park, KS 66210-2338 Ph: (913) 599-6777 | Michael E Brun, MD 9100 W 74th St, Shawnee Mission, KS 66204-4004 Ph: (913) 676-2310 |
News Archive
While the world waits eagerly for a safe and effective vaccine to prevent infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the COVID-19 pandemic, researchers also are focusing on better understanding how SARS-CoV-2 attacks the body in the search for other means of stopping its devastating impact.
Results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms reduced the amount of bacteria in the rooms by 97 percent and resulted in a 41 percent reduction in the hospital acquired infection rate.
The U.S. Food and Drug Administration (FDA) has announced the tentative approval of Lamivudine Tablets manufactured by Aurobindo Pharma LTD. Hyderabad, India.
PTS Diagnostics, the U.S.-based manufacturer of both the CardioChek brand and the A1CNow family of point-of-care diagnostic products, announces the launch of the PTS Connect Wellness Solution. This secure cloud-based solution will empower health screening companies to screen more individuals faster and corporate wellness programs to improve outcomes by encouraging participants to monitor and track activity and progress online.
Sanofi-aventis announced today it has commenced a tender offer for all outstanding shares of common stock of Genzyme Corporation for $69 per share, net to the seller in cash, without interest and less any required withholding taxes. The transaction is valued at approximately $18.5 billion.
› Verified 6 days ago
Michael J Gaughan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
John Yungmeyer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Jeffrey A Hicklin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Richard D Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Miss Kavita Chowdary Gorantla, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Michael W Dennis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2310 | |
Mark S Reinsel, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-599-6777 |